Is Seborrheic Dermatitis of Infancy and Childhood Related to In Utero Exposure to Antibiotics? A Population‐Based Cohort Study From the United Kingdom

IRB Approval Status: Study was approved by IMRD, the Scientific Review Committee (SRC) for UK Ethics as protocol number 22SRC042 and the University of Pennsylvania Institutional Review Board (IRB). Z.C.C.F. has received research grants from Lilly, LEO Pharma, Brexogen, Regeneron, Sanofi, Tioga, and Vanda for work related to atopic dermatitis and from Menlo Therapeutics and Galderma for work related to prurigo nodularis. She has also served as a consultant for the Asthma and Allergy Foundation of America, National Eczema Association, AbbVie, Incyte Corporation, and Pfizer; and received honoraria for CME work in Atopic Dermatitis sponsored by education grants from Regeneron/Sanofi and Pfizer and from Beirsdorf for work related to skin cancer and sun protection. E.A.G. is on the scientific advisory board for L'Oreal Advanced Research and is a consultant for Unilever. A.R., N.M., O.H., and D.J.M. have no relevant conflicts of interest. Data available within the article.